Triangle gains public company with merger Breakthrough! RTP biotech sees progress in restoring vision to blind Breakthrough!

The therapy, which delivers COL7A1 transgenes by eyedrop, was used previously to treat a patient under a compassionate use protocol.

Topline data were announced from a phase 3 trial evaluating ST-100 ophthalmic solution for the treatment of dry eye disease.

The trial is evaluating KB803 for the treatment and prevention of corneal abrasions in dystrophic epidermolysis bullosa ...

Blood biologics need not be reserved for advanced corneal conditions, Mahnia Madan, OD, FAAO, said in this Healio Video ...

Rose water isn’t just a fragrant beauty staple - it’s also gaining popularity as a gentle solution for irritated, dry, and ...

ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...

We're proud to announce a brand new soft plastic, the EYE DROPS! Great for tipping or using as is - get ready for some ...

Methods Forty consecutive patients with moderate to severe DED were included in a phase IIa, prospective, open label, multiple-dose, clinical trial to receive rhNGF eye drops at 20 µg/mL (Group 1: G1) ...